Company intelligence / Profile preview

Dr. Alejandro Sousa Escandón

Monforte de Lemos, Galicia, Spain

Ownership: Private
Development stage: Other

Overview

Dr. Alejandro Sousa Escandón is a specialized urological medical practice and clinical research entity based in Spain. Led by Dr. Alejandro Sousa Escandón, a prominent urologist and researcher, the entity focuses on advanced treatments for non-muscle invasive bladder cancer (NMIBC). The practice is notably recognized for its expertise in hyperthermic intravesical chemotherapy (HIVEC) and the use of the Combat BRS system for delivering mitomycin C. Dr. Sousa Escandón serves as a key investigator in clinical trials evaluating bladder-preserving oncological therapies and has published extensively on the efficacy of thermochemotherapy.

Therapeutic areas: Oncology
Modalities: Small moleculeDevice
Industry: Academic Hospital/University/Research

Partnerships

Combat Medical

Beyond the preview

Go deeper on Dr. Alejandro Sousa Escandón.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dr. Alejandro Sousa Escandón.

Explore the full profile